Zentalis Pharmaceuticals, Inc. (ZNTL)

Zentalis Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Zentalis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.50. The average 1-year stock price forecast is 61.69% higher than the current stock price, while the lowest is $4.00 (-0.50%) and the highest is $10 (+148.76%).

Price Target: $6.50 (+61.69%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$6.50	$5.50	$10
Change	-0.50%	+61.69%	+36.82%	+148.76%

Analyst Ratings

The average analyst rating for Zentalis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	4	4	4	3
Buy	0	0	0	0	0	0
Hold	5	5	5	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	9	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andres Y. Maldonado H.C. Wainwright	H.C. Wainwright	Buy Reiterates $10	Buy	Reiterates	$10	+148.76%	May 22, 2026
Unknown Analyst Wedbush No rating	Wedbush	Hold Maintains $4	Hold	Maintains	$4	-0.50%	May 13, 2026
Michael Ulz Morgan Stanley	Morgan Stanley	Hold Maintains $4	Hold	Maintains	$4	-0.50%	May 13, 2026
Matthew Biegler Oppenheimer	Oppenheimer	Buy Reiterates $9	Buy	Reiterates	$9	+123.88%	May 13, 2026
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Hold Reiterates $5	Hold	Reiterates	$5	+24.38%	May 13, 2026

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  21.85M
• EPS This Year:
  -1.92

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	67.43M	-	-	21.85M
Revenue Growth	-	-	-	-	-	-	-
EPS	-3.72	-4.48	-4.47	-2.33	-1.91	-1.92	-1.68
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	n/a	47.5M
Avg	n/a	21.9M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	-1.33	-0.85
Avg	-1.92	-1.68
Low	-2.21	-2.35

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.